cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1993; 21:90-98
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buxton, A.
Right arrow Articles by Miller, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buxton, A.
Right arrow Articles by Miller, J.

Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide

AE Buxton, ME Josephson, FE Marchlinski, and JM Miller

Clinical Electrophysiology Laboratory, Hospital of the University of Pennsylvania, Philadelphia.

OBJECTIVES. This study was designed to evaluate the effects of procainamide on polymorphic ventricular tachycardia induced by programmed stimulation and to correlate the responses with heart disease, left ventricular endocardial activation abnormalities and the signal-averaged electrocardiogram (ECG). BACKGROUND. Polymorphic ventricular tachycardia is induced frequently during electrophysiologic studies. In many patients this response is an artifact of programmed stimulation; in others, it appears to be clinically relevant. Previous observations have suggested that in some patients type IA antiarrhythmic agents can change the response to programmed stimulation from polymorphic to uniform ventricular tachycardia. METHODS. Programmed right ventricular stimulation was performed in the absence of antiarrhythmic drugs and after procainamide. Signal-averaged ECGs and left ventricular maps were performed during sinus rhythm in the absence of antiarrhythmic drugs. RESULTS. We evaluated 79 consecutive patients undergoing clinical electrophysiologic studies, in whom polymorphic ventricular tachycardia was the only arrhythmia induced in the absence of antiarrhythmic drugs. After procainamide administration, uniform monomorphic ventricular tachycardia was induced in 24 patients (Group 1), inducible polymorphic ventricular tachycardia persisted in 30 patients (Group 2) and no ventricular tachycardia could be induced in the remaining 25 patients (Group 3). Twenty-three (96%) of 24 patients developing uniform ventricular tachycardia after procainamide administration had coronary artery disease compared with 63% of Group 2 and 48% of Group 3 patients (p = 0.003). Left ventricular aneurysms were also found more frequently (46%) in the patients developing uniform ventricular tachycardia after procainamide than in either Group 2 or Group 3 (13% and 0%, respectively, p < 0.008). Abnormalities of the signal-averaged ECG typically seen in patients with spontaneous reentrant sustained ventricular tachycardia were significantly more frequent in patients who developed inducible uniform ventricular tachycardia after procainamide than in those who did not. Similarly, patients developing uniform ventricular tachycardia after procainamide had more extensive abnormalities of left ventricular endocardial activation revealed by catheter maps during sinus rhythm. CONCLUSIONS. The conversion of inducible polymorphic ventricular tachycardia to uniform ventricular tachycardia after procainamide administration occurs almost exclusively in patients with coronary disease, previous myocardial infarction and abnormal left ventricular function. This response may permit activation mapping of tachycardias, allowing the application of surgical or catheter ablation techniques that would otherwise not be possible in such patients.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. Bello, D. S. Fieno, R. J. Kim, F. S. Pereles, R. Passman, G. Song, A. H. Kadish, and J. J. Goldberger
Infarct morphology identifies patients with substrate for sustained ventricular tachycardia
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1104 - 1108.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Khairy, M. J. Landzberg, M. A. Gatzoulis, H. Lucron, J. Lambert, F. Marcon, M. E. Alexander, and E. P. Walsh
Value of Programmed Ventricular Stimulation After Tetralogy of Fallot Repair: A Multicenter Study
Circulation, April 27, 2004; 109(16): 1994 - 2000.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Huang, J. L. Skinner, J. M. Rogers, W. M. Smith, W. L. Holman, and R. E. Ideker
The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 375 - 383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-H. Kim, F. Xie, M. Yashima, T.-J. Wu, M. Valderrabano, M.-H. Lee, T. Ohara, O. Voroshilovsky, R. N. Doshi, M. C. Fishbein, et al.
Role of Papillary Muscle in the Generation and Maintenance of Reentry During Ventricular Tachycardia and Fibrillation in Isolated Swine Right Ventricle
Circulation, September 28, 1999; 100(13): 1450 - 1459.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Y. Kwan, W. Fan, D. Hough, J. J. Lee, M. C. Fishbein, H. S. Karagueuzian, and P.-S. Chen
Effects of Procainamide on Wave-Front Dynamics During Ventricular Fibrillation in Open-Chest Dogs
Circulation, May 12, 1998; 97(18): 1828 - 1836.
[Abstract] [Full Text] [PDF]



 
  cardiology careers collections past issues search home